Decision based on data involving use of SpaceOAR® hydrogel to protect surrounding tissue during radiotherapy to treat prostate cancer. BEDFORD, Mass.--(BUSINESS WIRE)--Augmenix, Inc., a medical ...
Recent advances in prostate cancer radiotherapy have prioritized techniques that minimize treatment-related toxicity and ...
SpaceOAR Hydrogel reduces radiation exposure to the rectum, minimizing bowel-related side effects in prostate cancer patients undergoing radiation therapy. A study showed a 25% reduction in bowel ...
Radiation-related bowel toxicity among real-world patients was lower with use of the rectal spacer. Use of a hydrogel rectal spacer reduces the incidence of bowel disorders and related procedures over ...
Prediction of significant prostate cancer in equivocal MRI lesions: A high-volume international multicenter study. This is an ASCO Meeting Abstract from the 2023 ASCO Genitourinary Cancers Symposium.
TORONTO--(BUSINESS WIRE)--Augmenix, Inc., a medical technology company that develops, manufactures, and sells proprietary absorbable hydrogels that separate and protect organs at risk during ...
A world-first study led by Austin Health's clinician-researchers has demonstrated the feasibility and safety of using stabilized hyaluronic acid (sHA) gel as a rectal spacer during radiation treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results